CVS Health Launches Cordavis

New business will bring high quality biosimilar products to market with goal of reducing drug spend and ensuring access to affordable medications Cordavis to launch biosimilar Hyrimoz® with Sandoz beginning in 2024 at more than 80% lower list price than Humira®* WOONSOCKET, R.I., Aug. 23,…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks